Mustang Bio, Inc.: Pioneering Immunotherapy for AML and Brain Cancer Amidst Biotech Challenges
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel cancer immunotherapy products, particularly for Acute Myeloid Leukemia (AML) and brain cancer, with a mission to transform cancer treatment through innovat…
3 minutes to read